IMPROVING CARDIORESPIRATORY PERFORMANCE IN DMD VIA COMBINATORIAL DYSTROPHIN AND RIBONUCLEOTIDE REDUCTASE GENE THERAPY

$1,119,658FY2018Defense Health AgencyDOD

University Of Washington, Seattle WA

Investigators